Provided by Tiger Fintech (Singapore) Pte. Ltd.

ProKidney Corp.

3.29
+0.03000.92%
Post-market: 3.28-0.0107-0.33%19:59 EDT
Volume:2.79M
Turnover:9.22M
Market Cap:438.93M
PE:-5.53
High:3.50
Open:3.40
Low:3.16
Close:3.26
Loading ...

UBS Adjusts ProKidney Price Target to $8 From $4, Maintains Buy Rating

MT Newswires Live
·
15 Jul

BRIEF-Prokidney Announces Alignment With The FDA On The Accelerated Approval Pathway For Rilparencel

Reuters
·
15 Jul

ProKidney Corp. Secures FDA Alignment for Accelerated Approval Pathway of Rilparencel in Advanced CKD and Type 2 Diabetes

Reuters
·
15 Jul

ProKidney price target raised to $8 from $4 at UBS

TIPRANKS
·
15 Jul

ProKidney Corp. Announces $200 Million Open Market Sale Agreement with Jefferies LLC

Reuters
·
15 Jul

ProKidney Is Maintained at Buy by Guggenheim

Dow Jones
·
14 Jul

Stock Track | ProKidney Corp. Plummets 8.49% Following Bank of America's $1 Price Target and Sell Rating

Stock Track
·
11 Jul

Stock Track | ProKidney Corp. Plummets 5.02% in Pre-market Following Bank of America's Sell Rating and $1 Price Target

Stock Track
·
11 Jul

Stock Track | ProKidney Corp. Plummets 5.02% in Pre-market Following Analyst's $1 Price Target

Stock Track
·
11 Jul

Stock Track | ProKidney Corp. Plunges 5.41% Following Bank of America's Sell Rating and $1 Price Target

Stock Track
·
11 Jul

ProKidney (PROK) Gets a Sell from Bank of America Securities

TIPRANKS
·
11 Jul

Stock Track | ProKidney Corp. Soars 24.88% on Continued Rally Following Positive Trial Results

Stock Track
·
10 Jul

Premarket Movers|Chinese Property Shares Rise with Fangdd up 17%; WK Kellogg Soars 49%; Nurix Therapeutics up 36%; ProKidney Surges 12%

Tiger Newspress
·
10 Jul

Stock Track | ProKidney Corp. Soars 20.28% Pre-market Following Positive Trial Results and Continued Rally

Stock Track
·
10 Jul

Stock Track | ProKidney Soars 5.99% as Positive Phase 2 Trial Results Continue to Fuel Rally

Stock Track
·
10 Jul

Stock Track | ProKidney Corp. Surges 5.99% as Positive Trial Results Continue to Fuel Investor Enthusiasm

Stock Track
·
10 Jul

Darin J. Weber, Chief Regulatory Officer, Reports Disposal of Prokidney Corp. Common Shares

Reuters
·
10 Jul

ProKidney Is Maintained at Buy by Citigroup

Dow Jones
·
10 Jul

ProKidney's Stock Rockets 63% After Soaring 515% Tuesday On Positive Phase 2 Trial Results

Tiger Newspress
·
09 Jul

Guggenheim Reaffirms Their Buy Rating on ProKidney (PROK)

TIPRANKS
·
09 Jul